Cancer Genetics, Inc. logo
Cancer Genetics, Inc. CGIX
$ 4.61 -2.33%

Cancer Genetics, Inc. Income Statement 2011-2024 | CGIX

Annual Income Statement Cancer Genetics, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

- 8.02 M 6.82 M 41.3 M 34.1 M 26.9 M 71.7 M 78.4 M - -

Shares

- 1.93 M 910 K 689 K 529 K 343 K 315 K 156 K - -

Net Income

-8 M - - - - - - - - -

Revenue

5.75 M - - - - - - - - -

EBITDA

-8.02 M - - - - - - - - -

Operating Expenses

10.6 M - - - - - - - - -

General and Administrative Expenses

6.6 M - - - - - - - - -

All numbers in USD currency